PACITAXELINE
DEAD

Serial Number

75599435

Owner

CHAICHEM PHARMACEUTICALS INC.

Attorney

Jennifer L. Dean

Filing Date

Nov 30, 1998

Add to watchlist:

No watchlists yet
View on USPTO

PACITAXELINE Trademark

Serial Number: 75599435 • Registration: 2785203

PACITAXELINE is a trademark filed by CHAICHEM PHARMACEUTICALS INC. on November 30, 1998. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

CHAICHEM PHARMACEUTICALS INC.

230 Bernard Belleau
Laval, Quebec H7V 4A9 , CA

Entity Type: 03

Trademark Details

Filing Date

November 30, 1998

Registration Date

November 25, 2003

Published for Opposition

September 2, 2003

Cancellation Date

June 27, 2014

Goods & Services

PHARMACEUTICAL PRODUCT PREPARATION USED IN CHEMOTHERAPY FOR THE TREATMENT OF BREAST CANCER

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jun 27, 2014 CAEX
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 22, 2009 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 21, 2009 APRE
TEAS SECTION 8 & 15 RECEIVED
Sep 9, 2009 E815
CASE FILE IN TICRS
Aug 7, 2008 CFIT
REGISTERED-PRINCIPAL REGISTER
Nov 25, 2003 R.PR
PUBLISHED FOR OPPOSITION
Sep 2, 2003 PUBO
NOTICE OF PUBLICATION
Aug 13, 2003 NPUB
Sec. 1(B) CLAIM DELETED
Jun 7, 2003 1.BD
REINSTATED
Mar 22, 2003 REIN
ABANDONMENT - NO USE STATEMENT FILED
Feb 14, 2003 ABN6
PAPER RECEIVED
Nov 22, 2002 MAIL
NOTICE OF ALLOWANCE CANCELLED
Nov 14, 2002 IUCN
PAPER RECEIVED
Nov 14, 2002 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
May 14, 2002 NOAM
PUBLISHED FOR OPPOSITION
Feb 19, 2002 PUBO
NOTICE OF PUBLICATION
Jan 30, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2001 CNSA
SEC. 44(D) CLAIM DELETED
Jun 15, 2000 44DD
LETTER OF SUSPENSION MAILED
Oct 20, 1999 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 1999 CRFA
NON-FINAL ACTION MAILED
Jun 30, 1999 CNRT
ASSIGNED TO EXAMINER
Jun 17, 1999 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 1999 CRFA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 17, 1999 AMPX